查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1458530

核酸分离与精製市场：全球规模、份额、趋势分析、机会、预测报告，2019-2030

Nucleic Acid Isolation and Purification Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Product ; By Type ; By Method ; By Application ; By End User ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球核酸分离精製市场规模将以9.23%的复合年增长率大幅扩张，2030年将达到84.7亿美元。

由于RNA疗法管道的不断扩大和基于核酸的诊断的日益普及，全球核酸分离和精製市场正在蓬勃发展。

领先的策略咨询和市场研究公司BlueWeave Consulting在最近的研究中预计，2023年全球核酸分离精製市场规模为42.2亿美元。 BlueWeave预测，2024年至2030年预测期内，全球核酸分离精製市场规模将以9.23%的复合年增长率成长，2030年达到84.7亿美元。加强研发力度和增加临床诊断定序平台的使用是全球核酸分离和精製市场的两个主要成长要素。基因组研究的增加和新产品的推出预计也将推动市场的发展。

机会：诊断应用的增加

全球核酸分离和精製市场按应用细分为药物发现/研发、精准医学、诊断、农业/动物研究等。诊断领域占全球核酸分离精製市场最大份额。根据 ScienceDirect 发表的一项研究，RNA/DNA 基因测试是识别感染疾病和确定一个人对某些疾病（包括 COVID-19）的易感性的最可靠方法。预计药物发现和开发将在预测期内实现最高成长率。

地缘政治紧张局势升级对全球核酸分离精製市场的影响

地缘政治紧张局势的加剧将限制全球核酸分离精製市场的成长。例如，乌克兰已成为各种疾病（尤其是癌症）临床研究和临床实验的主要目的地。由于存在有组织和数数位化的医疗系统，与许多其他西欧国家相比，乌克兰可以以较低的成本进行医学研究。然而，俄罗斯对乌克兰的入侵崩坏了该国的医学研究生态系统。根据多方通报，乌克兰拥有大量临床研究专家以及基础设施，直接影响核酸分离精製的需求，阻碍全球市场的成长。

全球核酸分离精製市场

按细分市场分類的覆盖范围

核酸分离和精製的全球市场 - 按方法分类

全球核酸分离精製市场依方法分为基于试剂的分离精製、基于管柱的分离精製、以微珠为基础的分离精製等。由于 DNA 和 RNA 分离和精製中检测性能的提高，以微珠为基础的分离和精製领域占据了最高的市场占有率。此外，与其他方法相比，该方法更快、更容易、更灵活，这使其具有竞争力并受到研究人员和科学家的青睐。

全球核酸分离与精製市场 - 按地区

关于全球核酸分离和精製市场的详细研究报告涵盖了五个主要地区的众多各国市场：北美、欧洲、亚太地区（APAC）、拉丁美洲以及中东和非洲。北美主导全球核酸分离精製市场。市场的推动因素是Thermo Scientific和Bio-Rad Laboratories等主要企业的集中，以及核酸精製系统研发力度和投资的加强。

竞争格局

全球核酸分离和精製市场的主要企业包括安捷伦科技、Bio-Rad Laboratories Inc.、Thermo Fisher Scientific、BioVision Inc.、丹纳赫公司、F. Hoffmann-La Roche Ltd.、GE Healthcare、Merck KGaA (Sigma) -Aldrich Corporation)、Promega Corporation、Qiagen NV、Invitek Molecular、Analytik Jena AG、Illumina, Inc. 和Takara Bio Inc.。

为了进一步增加市场占有率，这些公司正在采取各种策略，例如併购、合作、合资、授权合约和新产品发布。

该报告的详细分析提供了有关成长潜力、未来趋势和全球核酸分离与精製市场的资讯。它还涵盖了推动市场总规模预测的因素。该报告致力于提供全球核酸分离与精製市场的最新技术趋势以及产业见解，以帮助决策者做出策略决策。此外，我们也分析了市场的成长动力、挑战和竞争力。

目录

第一章 研究框架

第 2 章执行摘要

第三章全球核酸分离精製市场洞察

  • 产业价值链分析
    • DROC分析
    • 生长促进因子
      • 扩大RNA疗法的研发管线
      • 基于核酸的诊断越来越受欢迎
      • 技术进步
      • 扩大研究活动
    • 抑制因素
      • 监管挑战
      • 成本限制
      • 供应链中断
    • 机会
      • 对先进诊断技术的需求
      • 战略合作
      • 发展中地区市场拓展
    • 任务
      • 竞争很激烈
      • 技术复杂性
  • 科技进步/最新发展
  • 法律规范
  • 波特五力分析

第四章 全球核酸分离精製市场、价格分析

第五章全球核酸分离精製市场：行销策略

第六章全球核酸分离精製市场、区域分析

  • 世界市场，区域分析，2023 年
  • 世界市场，吸引力分析，2024-2030

第七章 全球核酸分离精製市场概况

  • 2019-2030年市场最终用户及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
      • 套件和试剂
      • 装置
      • 其他的
    • 按类型
      • 质体DNA 的分离与精製
      • 总RNA分离精製
      • 基因组 DNA 分离精製
      • 传讯RNA分离精製
      • 微型RNA分离精製
      • 循环核酸的分离与精製
      • PCR 纯化
      • 其他的
    • 依方法
      • 基于试剂的分离与精製
      • 管柱分离精製
      • 使用磁珠分离和精製
      • 其他的
    • 按申请
      • 药物发现与开发
      • 精准医疗
      • 诊断
      • 农业和动物研究
      • 其他的
    • 按最终用户
      • 医院
      • 诊断中心
      • 学术研究所
      • 合约调查机构
      • 製药和生物技术公司
      • 其他的
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区 (APAC)
      • 拉丁美洲 (LATAM)
      • 中东和非洲 (MEA)

第八章 北美核酸分离精製市场

  • 2019-2030年市场最终用户及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 按类型
    • 依方法
    • 按申请
    • 按最终用户
    • 按国家/地区
      • 美国
      • 加拿大

第九章欧洲核酸分离精製市场

  • 2019-2030年市场最终用户及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 按类型
    • 依方法
    • 按申请
    • 按最终用户
    • 按国家/地区
      • 德国
      • 英国
      • 义大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 其他的

第十章亚太地区核酸分离精製市场

  • 2019-2030年市场最终用户及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 按类型
    • 依方法
    • 按申请
    • 按最终用户
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳洲和纽西兰
      • 印尼
      • 马来西亚
      • 新加坡
      • 越南
      • 其他的

第十一章 拉美核酸分离精製市场

  • 2019-2030年市场最终用户及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 按类型
    • 依方法
    • 按申请
    • 按最终用户
    • 按国家/地区
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 其他的

第十二章 中东及非洲核酸分离精製市场

  • 2019-2030年市场最终用户及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 按类型
    • 依方法
    • 按申请
    • 按最终用户
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 科威特
      • 南非
      • 奈及利亚
      • 阿尔及利亚
      • 其他的

第十三章竞争格局

  • 主要参与者及其方法列表
  • 2023年全球核酸分离精製企业市场占有率分析
  • 透过管理参数进行竞争基准化分析
  • 重大策略发展（合併、收购、联盟等）

第十四章地缘政治紧张局势升级对全球核酸分离精製市场的影响

第十五章 公司简介（公司简介、财务矩阵、竞争格局、关键人员、主要竞争对手、联络方式、策略展望、SWOT分析）

  • Agilent Technologies
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific
  • BioVision Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Merck KGaA（Sigma-Aldrich Corporation）
  • Promega Corporation
  • Qiagen NV
  • Invitek Molecular
  • Analytik Jena AG
  • Illumina, Inc
  • Takara Bio Inc.
  • 其他主要企业

第十六章 主要策略建议

第十七章调查方法

简介目录
Product Code: BWC24238

Global Nucleic Acid Isolation and Purification Market Size Expands at Significant CAGR of 9.23% to Reach USD 8.47 Billion by 2030

Global Nucleic Acid Isolation and Purification Market is flourishing because of the expanding pipeline for RNA therapeutics and growing popularity of nucleic acid-based diagnostics.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Nucleic Acid Isolation and Purification Market size at USD 4.22 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Nucleic Acid Isolation and Purification Market size to expand at a CAGR of 9.23% reaching a value of USD 8.47 billion by 2030. Growing R&D efforts and an increase in the use of sequencing platforms for clinical diagnostics are two key growth drivers for the Global Nucleic Acid Isolation and Purification Market. The is also expected to be driven by an increase in genomics research as well as new product launches.

Opportunity: Rising application for diagnostics

The Global Nucleic Acid Isolation and Purification Market is segmented into drug discovery & development, precision medicine, diagnostics, agriculture and animal research, and other, based on application. The diagnostics segment holds the largest share in the Global Nucleic Acid Isolation and Purification Market. According to research published on ScienceDirect, RNA/DNA genetic tests are the most reliable for identifying infectious illnesses and determining a person's vulnerability to certain diseases, including COVID-19. Drug discovery and development is anticipated to register the highest growth rate during the forecast period.

Impact of Escalating Geopolitical Tensions on Global Nucleic Acid Isolation and Purification Market

The escalating geopolitical tensions restrict the growth of the Global Nucleic Acid Isolation and Purification Market. For instance, Ukraine has been emerging as the leading destination for clinical research and trials of various diseases, particularly cancer. The presence of an organized and digitized health system makes it cheaper to accommodate medical research in Ukraine compared to many other Western European nations. However, Russia's invasion of Ukraine disrupted the medical research ecosystem in the country. Many reports reveal that Ukraine has a large number of clinical research specialists as well as infrastructure, which directly impacts the demand for nucleic acid isolation and purification, hindering its global market growth.

Global Nucleic Acid Isolation and Purification Market

Segmental Coverage

Global Nucleic Acid Isolation and Purification Market - By Method

Based on method, the Global Nucleic Acid Isolation and Purification Market is segmented into reagent-based isolation & purification, column-based isolation & purification, magnetic bead-based isolation and purification, and others. The magnetic bead-based isolation and purification segment accounts for the highest market share due to improved assay performance in DNA and RNA isolation and purification. Additionally, this method is also faster, easier, and more flexible compared to other methods, which gives it a competitive edge over other methods, and therefore, is preferred by researchers and scientists.

Global Nucleic Acid Isolation and Purification Market - By Region

The in-depth research report on the Global Nucleic Acid Isolation and Purification Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, the Middle East and Africa. North America dominates the Global Nucleic Acid Isolation and Purification Market. The high concentration of major industry players, such as Thermo Scientific and Bio-Rad Laboratories Inc., and their increasing efforts and investments in the R&D of nucleic acid purification systems are driving the market.

Competitive Landscape

Major players operating in the Global Nucleic Acid Isolation and Purification Market include Agilent Technologies, Bio-Rad Laboratories Inc., Thermo Fisher Scientific, BioVision Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, GE Healthcare, Merck KGaA (Sigma-Aldrich Corporation), Promega Corporation, Qiagen NV, Invitek Molecular, Analytik Jena AG, Illumina, Inc., and Takara Bio Inc.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Nucleic Acid Isolation and Purification Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Nucleic Acid Isolation and Purification Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Nucleic Acid Isolation and Purification Market Insights

  • 3.1. Industry Value Chain Analysis
    • 3.1.1. DROC Analysis
    • 3.1.2. Growth Drivers
      • 3.1.2.1. Expanding Pipeline for RNA Therapeutics
      • 3.1.2.2. Growing Popularity of Nucleic Acid-based Diagnostics
      • 3.1.2.3. Technological Advancements
      • 3.1.2.4. Increasing Research Activities
    • 3.1.3. Restraints
      • 3.1.3.1. Regulatory Challenges
      • 3.1.3.2. Cost Constraints
      • 3.1.3.3. Supply Chain Disruptions
    • 3.1.4. Opportunities
      • 3.1.4.1. Advanced Diagnostic Techniques Demand
      • 3.1.4.2. Strategic Collaborations
      • 3.1.4.3. Market Expansion in Developing Regions
    • 3.1.5. Challenges
      • 3.1.5.1. High Competition
      • 3.1.5.2. Technological Complexity
  • 3.2. Technological Advancements/Recent Developments
  • 3.3. Regulatory Framework
  • 3.4. Porter's Five Forces Analysis
    • 3.4.1. Bargaining Power of Suppliers
    • 3.4.2. Bargaining Power of Buyers
    • 3.4.3. Threat of New Entrants
    • 3.4.4. Threat of Substitutes
    • 3.4.5. Intensity of Rivalry

4. Global Nucleic Acid Isolation and Purification Market, Pricing Analysis

5. Global Nucleic Acid Isolation and Purification Market: Marketing Strategies

6. Global Nucleic Acid Isolation and Purification Market, Geographical Analysis

  • 6.1. Global Nucleic Acid Isolation and Purification Market, Geographical Analysis, 2023
  • 6.2. Global Lateral Flow Assays, Market Attractiveness Analysis, 2024-2030

7. Global Nucleic Acid Isolation and Purification Market Overview

  • 7.1. Market End User & Forecast, 2019-2030
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
      • 7.2.1.1. Kits & Reagents
      • 7.2.1.2. Instruments
      • 7.2.1.3. Others
    • 7.2.2. By Type
      • 7.2.2.1. Plasmid DNA Isolation & Purification
      • 7.2.2.2. Total RNA Isolation & Purification
      • 7.2.2.3. Genomic DNA Isolation & Purification
      • 7.2.2.4. Messenger RNA Isolation & Purification
      • 7.2.2.5. Micro RNA Isolation & Purification
      • 7.2.2.6. Circulating Nucleic Acid Isolation & Purification
      • 7.2.2.7. PCR Cleanup
      • 7.2.2.8. Others
    • 7.2.3. By Method
      • 7.2.3.1. Reagent-based Isolation & Purification
      • 7.2.3.2. Column-based Isolation & Purification
      • 7.2.3.3. Magnetic Bead-based Isolation & Purification
      • 7.2.3.4. Others
    • 7.2.4. By Application
      • 7.2.4.1. Drug Discovery & Development
      • 7.2.4.2. Precision Medicine
      • 7.2.4.3. Diagnostics
      • 7.2.4.4. Agriculture & Animal Research
      • 7.2.4.5. Others
    • 7.2.5. By End User
      • 7.2.5.1. Hospitals
      • 7.2.5.2. Diagnostic Centers
      • 7.2.5.3. Academic & Research Institutes
      • 7.2.5.4. Contract Research Organizations
      • 7.2.5.5. Pharmaceutical & Biotechnology Companies
      • 7.2.5.6. Others
    • 7.2.6. By Region
      • 7.2.6.1. North America
      • 7.2.6.2. Europe
      • 7.2.6.3. Asia Pacific (APAC)
      • 7.2.6.4. Latin America (LATAM)
      • 7.2.6.5. Middle East and Africa (MEA)

8. North America Nucleic Acid Isolation and Purification Market

  • 8.1. Market End User & Forecast, 2019-2030
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Type
    • 8.2.3. By Method
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
      • 8.2.6.1. United States
      • 8.2.6.1.1. By Product
      • 8.2.6.1.2. By Type
      • 8.2.6.1.3. By Method
      • 8.2.6.1.4. By Application
      • 8.2.6.1.5. By End User
      • 8.2.6.2. Canada
      • 8.2.6.2.1. By Product
      • 8.2.6.2.2. By Type
      • 8.2.6.2.3. By Method
      • 8.2.6.2.4. By Application
      • 8.2.6.2.5. By End User

9. Europe Nucleic Acid Isolation and Purification Market

  • 9.1. Market End User & Forecast, 2019-2030
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Type
    • 9.2.3. By Method
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
      • 9.2.6.1. Germany
      • 9.2.6.1.1. By Product
      • 9.2.6.1.2. By Type
      • 9.2.6.1.3. By Method
      • 9.2.6.1.4. By Application
      • 9.2.6.1.5. By End User
      • 9.2.6.2. United Kingdom
      • 9.2.6.2.1. By Product
      • 9.2.6.2.2. By Type
      • 9.2.6.2.3. By Method
      • 9.2.6.2.4. By Application
      • 9.2.6.2.5. By End User
      • 9.2.6.3. Italy
      • 9.2.6.3.1. By Product
      • 9.2.6.3.2. By Type
      • 9.2.6.3.3. By Method
      • 9.2.6.3.4. By Application
      • 9.2.6.3.5. By End User
      • 9.2.6.4. France
      • 9.2.6.4.1. By Product
      • 9.2.6.4.2. By Type
      • 9.2.6.4.3. By Method
      • 9.2.6.4.4. By Application
      • 9.2.6.4.5. By End User
      • 9.2.6.5. Spain
      • 9.2.6.5.1. By Product
      • 9.2.6.5.2. By Type
      • 9.2.6.5.3. By Method
      • 9.2.6.5.4. By Application
      • 9.2.6.5.5. By End User
      • 9.2.6.6. Belgium
      • 9.2.6.6.1. By Product
      • 9.2.6.6.2. By Type
      • 9.2.6.6.3. By Method
      • 9.2.6.6.4. By Application
      • 9.2.6.6.5. By End User
      • 9.2.6.7. Russia
      • 9.2.6.7.1. By Product
      • 9.2.6.7.2. By Type
      • 9.2.6.7.3. By Method
      • 9.2.6.7.4. By Application
      • 9.2.6.7.5. By End User
      • 9.2.6.8. The Netherlands
      • 9.2.6.8.1. By Product
      • 9.2.6.8.2. By Type
      • 9.2.6.8.3. By Method
      • 9.2.6.8.4. By Application
      • 9.2.6.8.5. By End User
      • 9.2.6.9. Rest of Europe
      • 9.2.6.9.1. By Product
      • 9.2.6.9.2. By Type
      • 9.2.6.9.3. By Method
      • 9.2.6.9.4. By Application
      • 9.2.6.9.5. By End User

10. Asia Pacific Nucleic Acid Isolation and Purification Market

  • 10.1. Market End User & Forecast, 2019-2030
    • 10.1.1. By Value (USD Billion)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Type
    • 10.2.3. By Method
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
      • 10.2.6.1. China
      • 10.2.6.1.1. By Product
      • 10.2.6.1.2. By Type
      • 10.2.6.1.3. By Method
      • 10.2.6.1.4. By Application
      • 10.2.6.1.5. By End User
      • 10.2.6.2. India
      • 10.2.6.2.1. By Product
      • 10.2.6.2.2. By Type
      • 10.2.6.2.3. By Method
      • 10.2.6.2.4. By Application
      • 10.2.6.2.5. By End User
      • 10.2.6.3. Japan
      • 10.2.6.3.1. By Product
      • 10.2.6.3.2. By Type
      • 10.2.6.3.3. By Method
      • 10.2.6.3.4. By Application
      • 10.2.6.3.5. By End User
      • 10.2.6.4. South Korea
      • 10.2.6.4.1. By Product
      • 10.2.6.4.2. By Type
      • 10.2.6.4.3. By Method
      • 10.2.6.4.4. By Application
      • 10.2.6.4.5. By End User
      • 10.2.6.5. Australia & New Zealand
      • 10.2.6.5.1. By Product
      • 10.2.6.5.2. By Type
      • 10.2.6.5.3. By Method
      • 10.2.6.5.4. By Application
      • 10.2.6.5.5. By End User
      • 10.2.6.6. Indonesia
      • 10.2.6.6.1. By Product
      • 10.2.6.6.2. By Type
      • 10.2.6.6.3. By Method
      • 10.2.6.6.4. By Application
      • 10.2.6.6.5. By End User
      • 10.2.6.7. Malaysia
      • 10.2.6.7.1. By Product
      • 10.2.6.7.2. By Type
      • 10.2.6.7.3. By Method
      • 10.2.6.7.4. By Application
      • 10.2.6.7.5. By End User
      • 10.2.6.8. Singapore
      • 10.2.6.8.1. By Product
      • 10.2.6.8.2. By Type
      • 10.2.6.8.3. By Method
      • 10.2.6.8.4. By Application
      • 10.2.6.8.5. By End User
      • 10.2.6.9. Vietnam
      • 10.2.6.9.1. By Product
      • 10.2.6.9.2. By Type
      • 10.2.6.9.3. By Method
      • 10.2.6.9.4. By Application
      • 10.2.6.9.5. By End User
      • 10.2.6.10. Rest of APAC
      • 10.2.6.10.1. By Product
      • 10.2.6.10.2. By Type
      • 10.2.6.10.3. By Method
      • 10.2.6.10.4. By Application
      • 10.2.6.10.5. By End User

11. Latin America Nucleic Acid Isolation and Purification Market

  • 11.1. Market End User & Forecast, 2019-2030
    • 11.1.1. By Value (USD Billion)
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Type
    • 11.2.3. By Method
    • 11.2.4. By Application
    • 11.2.5. By End User
    • 11.2.6. By Country
      • 11.2.6.1. Brazil
      • 11.2.6.1.1. By Product
      • 11.2.6.1.2. By Type
      • 11.2.6.1.3. By Method
      • 11.2.6.1.4. By Application
      • 11.2.6.1.5. By End User
      • 11.2.6.2. Mexico
      • 11.2.6.2.1. By Product
      • 11.2.6.2.2. By Type
      • 11.2.6.2.3. By Method
      • 11.2.6.2.4. By Application
      • 11.2.6.2.5. By End User
      • 11.2.6.3. Argentina
      • 11.2.6.3.1. By Product
      • 11.2.6.3.2. By Type
      • 11.2.6.3.3. By Method
      • 11.2.6.3.4. By Application
      • 11.2.6.3.5. By End User
      • 11.2.6.4. Peru
      • 11.2.6.4.1. By Product
      • 11.2.6.4.2. By Type
      • 11.2.6.4.3. By Method
      • 11.2.6.4.4. By Application
      • 11.2.6.4.5. By End User
      • 11.2.6.5. Rest of LATAM
      • 11.2.6.5.1. By Product
      • 11.2.6.5.2. By Type
      • 11.2.6.5.3. By Method
      • 11.2.6.5.4. By Application
      • 11.2.6.5.5. By End User

12. Middle East and Africa Nucleic Acid Isolation and Purification Market

  • 12.1. Market End User & Forecast, 2019-2030
    • 12.1.1. By Value (USD Billion)
  • 12.2. Market Share & Forecast
    • 12.2.1. By Product
    • 12.2.2. By Type
    • 12.2.3. By Method
    • 12.2.4. By Application
    • 12.2.5. By End User
    • 12.2.6. By Country
      • 12.2.6.1. Saudi Arabia
      • 12.2.6.1.1. By Product
      • 12.2.6.1.2. By Type
      • 12.2.6.1.3. By Method
      • 12.2.6.1.4. By Application
      • 12.2.6.1.5. By End User
      • 12.2.6.2. UAE
      • 12.2.6.2.1. By Product
      • 12.2.6.2.2. By Type
      • 12.2.6.2.3. By Method
      • 12.2.6.2.4. By Application
      • 12.2.6.2.5. By End User
      • 12.2.6.3. Qatar
      • 12.2.6.3.1. By Product
      • 12.2.6.3.2. By Type
      • 12.2.6.3.3. By Method
      • 12.2.6.3.4. By Application
      • 12.2.6.3.5. By End User
      • 12.2.6.4. Kuwait
      • 12.2.6.4.1. By Product
      • 12.2.6.4.2. By Type
      • 12.2.6.4.3. By Method
      • 12.2.6.4.4. By Application
      • 12.2.6.4.5. By End User
      • 12.2.6.5. South Africa
      • 12.2.6.5.1. By Product
      • 12.2.6.5.2. By Type
      • 12.2.6.5.3. By Method
      • 12.2.6.5.4. By Application
      • 12.2.6.5.5. By End User
      • 12.2.6.6. Nigeria
      • 12.2.6.6.1. By Product
      • 12.2.6.6.2. By Type
      • 12.2.6.6.3. By Method
      • 12.2.6.6.4. By Application
      • 12.2.6.6.5. By End User
      • 12.2.6.7. Algeria
      • 12.2.6.7.1. By Product
      • 12.2.6.7.2. By Type
      • 12.2.6.7.3. By Method
      • 12.2.6.7.4. By Application
      • 12.2.6.7.5. By End User
      • 12.2.6.8. Rest of MEA
      • 12.2.6.8.1. By Product
      • 12.2.6.8.2. By Type
      • 12.2.6.8.3. By Method
      • 12.2.6.8.4. By Application
      • 12.2.6.8.5. By End User

13. Competitive Landscape

  • 13.1. List of Key Players and Their Methods
  • 13.2. Global Nucleic Acid Isolation and Purification Company Market Share Analysis, 2023
  • 13.3. Competitive Benchmarking, By Operating Parameters
  • 13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

14. Impact of Escalating Geopolitical Tensions on Global Nucleic Acid Isolation and Purification Market

15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 15.1. Agilent Technologies
  • 15.2. Bio-Rad Laboratories Inc.
  • 15.3. Thermo Fisher Scientific
  • 15.4. BioVision Inc.
  • 15.5. Danaher Corporation
  • 15.6. F. Hoffmann-La Roche Ltd
  • 15.7. GE Healthcare
  • 15.8. Merck KGaA (Sigma-Aldrich Corporation)
  • 15.9. Promega Corporation
  • 15.10. Qiagen NV
  • 15.11. Invitek Molecular
  • 15.12. Analytik Jena AG
  • 15.13. Illumina, Inc
  • 15.14. Takara Bio Inc.
  • 15.15. Other Prominent Players

16. Key Strategic Recommendations

17. Research Methodology

  • 17.1. Qualitative Research
    • 17.1.1. Primary & Secondary Research
  • 17.2. Quantitative Research
  • 17.3. Market Breakdown & Data Triangulation
    • 17.3.1. Secondary Research
    • 17.3.2. Primary Research
  • 17.4. Breakdown of Primary Research Respondents, By Region
  • 17.5. Assumptions & Limitations